EN News

News

Here you will find the latest news and updates about PHARMAQ part of Zoetis and our subsidiaries PHARMAQ Analytiq and PHARMAQ Fishteq.

pharmaq 3/25/2021

PHARMAQ Analytiq & FishVet Group double histopathology capacity

pharmaq 7/1/2020

Zoetis Acquires Fish Vet Group to Enhance Aquaculture Diagnostic Capabilities

pharmaq 5/25/2019

Vietnam and Norway exchanged inspiration to support sustainable growth in the Pangasius industry

pharmaq 5/4/2021

FishVet Group rebrands to PHARMAQ Analytiq

pharmaq 6/7/2021

Research article in Journal of Fish Diseases about Pasteurella spp. Infections in Atlantic salmon and lumpsucker

pharmaq 11/1/2021

Bernt Martinsen appointed as new Senior Vice President of PHARMAQ

pharmaq 2/8/2022

PHARMAQ Analytiq announces the opening of a new laboratory to enhance aquaculture diagnostic capabilities in Scotland

pharmaq 3/9/2022

PHARMAQademy Webinar, June 10, 2022

pharmaq 1/13/2023

PHARMAQademy UK 2023

PHARMAQ AS

Head office/Production facility
Skogmo Industriområde
Industrivegen 50
N-7863 Overhalla, Norway
Tel:+47 74 28 08 00

PHQ.customer.service@zoetis.com

Subscribe to Pharmaq newsletter

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com. Privacy Policy. Cookie Policy. Terms of Use.